Pharma news
Refine search
Americas
Allergan has transferred its patent rights for a dry eye treatment to a Native American tribe, in a bid to obtain immunity against an inter partes review (IPR). 11 September 2017
Americas
Forward Pharma has filed its opening brief in an appeal against a decision by the Patent Trial and Appeal Board (PTAB). 7 September 2017
Americas
There are two major challenges facing the life sciences IP arena, according to Larry Coury, senior director of dispute resolution at Regeneron. 7 September 2017
Americas
Two biotech associations have filed litigation in a district court challenging the provisions of a Nevada law, saying it violates patent rights. 7 September 2017
Americas
Industrial gases company Praxair has been cleared of patent infringement in a district court ruling after Mallinckrodt accused the company of infringing its respiratory treatment Inomax (nitric oxide). 6 September 2017
Americas
Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have entered a second round of litigation against Kite, a company which specialises in cancer immunotherapy treatments. 5 September 2017
Americas
Indivior, which specialises in addiction treatment drugs, intends to launch an appeal against a US District Court for the District of Delaware verdict that could lead to rival companies selling a generic version of its Suboxone Film, a drug to treat opioid addiction. 4 September 2017
Americas
The California Life Sciences Association (CLSA), an advocacy group, has added six new members to its board of directors. 1 September 2017
Asia-Pacific
The Australian government has rejected proposals by the Productivity Commission regarding extending the length of pharmaceutical patents. 31 August 2017
Americas
The Federal Trade Commission has approved a final order combating the anticompetitive effects resulting from Baxter’s proposed $625 million acquisition of Claris’s injectable drugs business. 31 August 2017